Program Director/Principal Investigator (Last, First, Middle): T o t O , R o b e r t D . PROJECT SUMMARY (See instmctions): The CTSA has had a major impact on the clinical and translational research (CTR) environment at UT Southwestern. Many new and highly successful programs in education and training, pilot grant awards, biomedical informatics (BMI), biostatistics, population research, community health sciences, and patient- centered outcomes research have been established. Concurrently, the CTSA stimulated UT Southwestern to invest heavily in CTR infrastructure by recruiting new clinical and translational researchers into leadership positions of major clinical departments, by creating a new research institute that focuses on stem cell biology and cancer and by greatly enhancing genomics, metabolomics, proteomics, bioinformatics, and systems biology. Two new, state-of-the art hospitals are under construction, to open in fall 2014, and they incorporate design elements that will support CTR. Our vision is to accelerate translation of new discoveries into clinical practice (T0-T4) by leveraging our scientific strengths. We will integrate and centralize our resources to work in an encouraging and collaborative research environment. Our three Specific Aims are to: 1) Enhance our Research Environment to Accelerate Translation of Discovery into Practice. We formed the Center for Translational Medicine (Center), directed by the CTSA PI, to serve as the new integrated home for our CTSA. The Center will coordinate and expand the clinical research enterprise while it educates clinical and translational researchers at every level. 2) Leverage Existinq and New Resources to Build on Four Innovative Programs in Translation including: a) Target Identification and Validation;b) Discovery in Humans;c) Intervention in Humans and d) Population Science and Community Engagement. 3) Share Knowledge and Discoverv. and Contribute to the Leadership of the National Consortium. We will share gains that are made in our programs in educational and translational research programs with the Texas Regional CTSA consortium and National CTSA Consortium. We will contribute to leadership in areas of translation including T0-T4 research, and discovery and commercialization of new drugs and devices. Our vision for accelerating CTR is well aligned with the new NCATS initiatives and takes full advantage of gains made in the previous funding. We will establish new and improved programs that will enable investigators to discover, translate and disseminate new knowledge that will improve the prevention, detection, diagnosis, and effective treatment of disease.

Public Health Relevance

Improving the health of our nation requires a concerted effort by medical scientists, health care providers and public health policymakers. This grant application will provide the crucial infrastructure necessary for medical scientists to discover and apply new diagnostics and therapeutics for the detection, prevention, detection, diagnosis and effective treatment of disease. The goal is to accelerate the movement of these new discoveries into clinical practice to improve our nation's health in a safe and effective manner.

National Institute of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
Linked Specialized Center Cooperative Agreement (UL1)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-PTM-C (S2))
Program Officer
Talbot, Bernard
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Chen, Yan; Zhang, Bo; Bao, Lei et al. (2018) ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis. J Clin Invest 128:1937-1955
Zhou, Zhengyang; Ku, Hung-Chih; Xing, Guan et al. (2018) Decomposing Pearson's ?2 test: A linear regression and its departure from linearity. Ann Hum Genet 82:318-324
Thodeson, Drew M; Brulet, Rebecca; Hsieh, Jenny (2018) Neural stem cells and epilepsy: functional roles and disease-in-a-dish models. Cell Tissue Res 371:47-54
Thomas-Jardin, Shayna E; Kanchwala, Mohammed S; Jacob, Joan et al. (2018) Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells. Prostate 78:595-606
Pierdomenico, Sante D; Pierdomenico, Anna M; Coccina, Francesca et al. (2018) Prognostic Value of Masked Uncontrolled Hypertension. Hypertension 72:862-869
Zhang, Honghui; Su, Jianzhong; Wang, Qingyun et al. (2018) Predicting seizure by modeling synaptic plasticity based on EEG signals - a case study of inherited epilepsy. Commun Nonlinear Sci Numer Simul 56:330-343
Patni, Nivedita; Quittner, Claudia; Garg, Abhimanyu (2018) Orlistat Therapy for Children With Type 1 Hyperlipoproteinemia: A Randomized Clinical Trial. J Clin Endocrinol Metab 103:2403-2407
Holbein, M E Blair; Weatherwax, Kevin J; Gravelin, Misty et al. (2018) Right now, in the right way: U. S. Food and Drug Administration's expanded access program and patient rights. J Clin Transl Sci 2:115-117
Makam, Anil N; Nguyen, Oanh Kieu; Xuan, Lei et al. (2018) Factors Associated With Variation in Long-term Acute Care Hospital vs Skilled Nursing Facility Use Among Hospitalized Older Adults. JAMA Intern Med 178:399-405
Rho, Jason; Ahn, Chul; Gao, Ang et al. (2018) Disparities in Mortality of Hispanic Patients with Cystic Fibrosis in the United States. A National and Regional Cohort Study. Am J Respir Crit Care Med 198:1055-1063

Showing the most recent 10 out of 520 publications